MedTrace Logo

SuperNOVA Clinical Stenting Trial

NCT01292928 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 299

Last updated 2017-03-08

Study results available
· View outcomes & findings →

Summary

The primary objective of this clinical study is to determine whether the Innova Stent System shows acceptable performance in long-term (12-month) safety rates and vessel patency when treating femoropopliteal lesions.

Conditions

  • Atherosclerosis of Native Arteries of the Extremities, Unspecified

Interventions

DEVICE

Stent implantation

Stent implantation during the index procedure.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Richard J Powell, MD · Dartmouth-Hitchcock Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2014-07-31
Completion
2016-09-30

Countries

  • United States
  • Austria
  • Belgium
  • Canada
  • Germany
  • Japan
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01292928 on ClinicalTrials.gov